Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.

• Main Authors: Alafeefy, Ahmed M., Ashour, Abdelkader Elbadawy Abbas, Prasad, Onkar, Sinha, Leena, Pathak, Shilendra, Alasmari, Fatimah A., Rishi, Arun K., Abdel-Aziz, Hatem A.
• Format: Article
• Language: English; English
• Published: Elsevier 2015
• Subjects: RM300 Drugs and their action
• Online Access: http://irep.iium.edu.my/66942/1/Development%20of%20certain%20novel%20N-%282-%282-%282-oxoindolin-3-ylidene%29hydrazinecarbonyl%29phenyl%29-benzamides%20and%203-%282-oxoindolin-3-ylideneamino%29-2-substituted%20quinazolin-4%283H%29-ones%20as%20CFM-1%20analogs.pdf; http://irep.iium.edu.my/66942/7/66942_Scopus%20-%20Document%20details.pdf; http://irep.iium.edu.my/66942/; https://www.sciencedirect.com/journal/european-journal-of-medicinal-chemistry

The reaction of N-(2-(hydrazinecarbonyl)aryl)benzamides 2a, b with indoline-2,3-diones 4ae in acidified ethanolic solution furnished the corresponding N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)benzamides 5aj, respectively. Furthermore, 3-(2-oxoindolin-3-ylideneamino)-2-substituted qui...